Arturo Palencia, MD
Pain Medicine · Bakersfield, CANPI 1104890151
Payments from drug & device makers
Across 403 payments — averaging $35.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Nevro Corp.$3K
- Vertiflex, Inc.$2K
- Spinal Simplicity, LLC$1K
- Collegium Pharmaceutical, Inc.$1K
- Painteq LLC$627
- plus $3K from 24 others
What the payments were for
- Travel & lodging$2,73819%
- Food & beverage$11,52081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 116 | $3,557 |
| Nevro Corp. | 92 | $2,882 |
| Vertiflex, Inc. | 11 | $2,024 |
| Spinal Simplicity, LLC | 10 | $1,241 |
| Collegium Pharmaceutical, Inc. | 68 | $1,201 |
| Painteq LLC | 11 | $627 |
| Globus Medical | 22 | $602 |
| Medtronic(2 entities) | 15 | $602 |
| Flowonix Medical Incorporated | 1 | $357 |
| Scilex Pharmaceuticals Inc. | 14 | $248 |
| Biodelivery Sciences International, Inc. | 12 | $242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $131 |
| Stratus Medical, LLC | 1 | $69 |
| Avanos Medical | 1 | $61 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Pfizer | 3 | $42 |
| Si-bone, Inc. | 2 | $39 |
| Abbott | 1 | $34 |
| Relievant Medsystems, Inc. | 1 | $32 |
| Protega Pharmaceutials Inc | 1 | $29 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Vertex | 1 | $22 |
| GRT US Holding, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $15 |
| Merit Medical Systems Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,632
- HA MINUTEMAN G3-R$1,017
- Senza$479
- GENERAL PAIN MANAGEMENT$447
- PAINTEQ$408
- Prometra II$357
- INTELLIS ADAPTIVESTIM$254
- Senza Spinal Cord Stimulation System$253
- SPECTRA WAVEWRITER$130
- Vyrsa V1$105
- GENERAL - THERAPIES$100
How this compares
$14,258 in reported general payments places this provider in the 85th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,982 | $48,419 |
| RelistorMethylnaltrexone Bromide | 18 | $43,338 |
| Buprenorphine | 141 | $30,334 |
| OxycontinOxycodone Hcl | 59 | $25,981 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 721 | $24,428 |
| Nucynta ErTapentadol Hcl | 17 | $16,656 |
| Fentanyl | 122 | $14,027 |
| Xtampza ErOxycodone Myristate | 18 | $13,209 |
| Morphine Sulfate ErMorphine Sulfate | 485 | $11,879 |
| MovantikNaloxegol Oxalate | 22 | $11,592 |
| Oxycodone Hcl | 330 | $7,474 |
| Pregabalin | 200 | $5,145 |
| Tramadol Hcl ErTramadol Hcl | 35 | $3,370 |
| Gabapentin | 328 | $3,173 |
| Cyclobenzaprine Hcl | 417 | $2,548 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $131 | $43,33818 claims |
| Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er | $1,201 | $29,86635 claims |
| Redhill Biopharma Inc.Movantik | $18 | $11,59222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 840 pain medicine providers in California.
Other pain medicine in Bakersfield
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
- Jacqueline WeisbeinNapa$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.